Related by context. All words. (Click for frequent words.) 67 genotype 1a 65 Woitas grounded 64 HOCH grounded 64 NEGRON K. grounded 63 GONZALES grounded 63 HOLLINGER E grounded 62 CLUFF grounded 62 WHITELEY grounded 61 BEL Kawasaki 61 VILLEZCAS grounded 60 NAKAYAMA grounded 60 WALTON flied 60 J. Vriesman grounded 60 Gradoville grounded 60 Morizio grounded 59 NIELSEN grounded 59 IFN α 59 WALTON grounded 59 A. Vedders 59 WELLS flied 59 RAMIREZ grounded 59 ROHAN flied 59 Steven Frossard FRA Kawasaki 59 HOLLINGER E flied 58 Pilittere grounded 58 Maximilian Nagl GER KTM 58 Joel Roelants BEL KTM 58 Jeffrey Herlings NED KTM 58 Xavier Boog FRA Kawasaki 58 TREMBLAY grounded 58 KELLER P. grounded 58 TEUFEL S. 58 Rui Goncalves POR KTM 58 2b SAC 58 Tamsin flied 58 Sebastien Pourcel FRA Kawasaki 58 % #gt 58 C. Sukalski 58 B. Gargon 58 Fleer K. 57 Joshua Coppins NZL Yamaha 57 neutrophil counts 57 Antonio Cairoli ITA Yamaha 57 Joshua Coppins NZL Aprilia 57 Gautier Paulin FRA Yamaha 57 lactate dehydrogenase 57 CLUFF flied 57 IFN g 57 KELLER P. flied 57 NIELSEN flied 57 Emanuele flied 57 Antonio Cairoli ITA KTM 57 transfected 57 pT3 57 M. Cieszko 57 K. Erkert 56 Davide Guarneri ITA Yamaha 56 ZINANTI 56 L. Politan grounded 56 G. Constanti 56 Ellis Yoland 56 VILLEZCAS flied 56 AYOSO 56 bunt SAC 56 TIMP 1 56 uM 56 A. Livsey 56 C. Mamigonia 56 biochemical relapse 56 BAILEY Natas 56 M. Giacoia 55 ALT elevation 55 URINCHO 55 bronchoalveolar lavage fluid 55 J. Sitzer 55 S. Ehlert 55 ISHIDA Miche 55 C. Eul 55 Dood J 55 Gruppen L 55 Marvin Musquin FRA KTM 55 K. Folkerts 55 N. Poissant 55 Histone H3 55 FEELEY J. 55 #-# BBBK 55 WINTTER L. 55 1ac 55 QUIOCHO 55 J. Buteyn 55 WIENS 55 relapsed MM 55 LINDLEY N. 55 H. Subich 55 M. Gaustad 55 A. Miksic 55 P. Devoy 55 A. Tiejema 55 LOWE T. 54 Christophe Charlier FRA Yamaha 54 M. Margel 54 Fig. 1b 54 Gustavus Adolphus 6th 54 B. Brummel 54 BEL KTM 54 -#.# log# copies mL 54 BREAM D. 54 Polloni Z. 54 F.Lewis 54 LANDIS Rober 54 lactate dehydrogenase LDH 54 VAN GORDEN 54 M. Palestina 54 E. Wendorff 54 K. Stira 54 G.Sanchez 54 BEL Suzuki 54 KRAS wild 54 intramuscularly 54 cyclin dependent kinase 54 SUTTON Asha 54 REYATAZ r arm 54 Fleer A. 54 treatment naive genotype 54 Senterrio La 54 papillary renal cell carcinoma 54 EAAT2 54 mg qd 54 DELAHOUSSAYE 54 SPENIA S. 54 bleomycin 54 TOTH N. 54 n # # 54 HUVEC 54 underwent surgical resection 54 D. Hegman 54 beta2 54 Pasdo 54 AUC0 53 severe NCI Grades 53 S. Piscitell 53 L. VanEnk 53 immunostaining 53 Dav.Murphy 53 VANCE KELLUM 53 μmol L 53 BUSSEY T. 53 cisplatin resistant 53 IFN beta 53 Ken Roczen GER 53 Caricofe B. 53 Z. Van Dyke 53 CORNSTUBBLE 53 VILLEZCAS 53 μg L 53 ^ sup -1 53 P. Groot 53 urinary excretion 53 L. Habisch 53 Harpine C. 53 CC genotype 53 Index CDAI 53 C. Dahlhaus 53 Maropis M 53 SHEPPARD Lak 53 leukocyte count 53 Kinesin Spindle Protein KSP 53 4mg/kg 53 KACENGA 53 KNELL 53 HepG2 cells 53 A.Jackson 53 mg kg dose 53 C. Ciccione 53 DYGERT 53 K. Valenta 53 KACENGA C. 53 Durakis C 53 D. Czuchaj 53 Corey Whitin 53 D. Cattrysse 53 methyltransferase 53 mean ± SEM 53 homozygote 53 TOKARZ 53 C.Young 53 pmol 53 LABOY R. 53 EVERHART J. 53 T. Wermedal 53 GRAY Tye 53 surgically resected 52 IU ml 52 ALDEN M. 52 transduced 52 hepatocellular carcinomas 52 HIESTAND 52 52 ovariectomized 52 B. Nikolski 52 1b 2b 52 Juntunen J. 52 CR nPR 52 L.Nix 52 N. Recknagel 52 μg ml 52 MICHON 52 G.Parra 52 Fv 52 C.Izturis 52 Glevenyak J 52 C.Ross 52 prostate carcinoma 52 M. Muscatiel 52 M. Stob 52 LOISEL B. 52 MOSCH 52 BEAN S. 52 2ac 52 J. Scelzo 52 nmol 52 alt Sec 52 K.Suzuki 52 Clk 52 ZOLLMAN 52 STROUPE 52 CD# CD# 52 BEL Yamaha 52 NMP# protein 52 μg kg 52 % #lt ;/ 52 STRICKLAND J 52 Fig. 2A 52 KIPKE 52 V.Wells 52 oxidative metabolism 52 A. Vicaro 52 plasmid encoding 52 de novo synthesis 52 Ashley Kivett 52 A. Rochminsk 52 S. Finkbeine 52 CLOWARD 52 RAUCH Jamee 52 L. Scarbroug 52 MCMILLON K. 52 spud #-#-# drlg [003] 52 J.Bautista 52 2b bunt 52 LV ejection fraction 52 cytokines IL 52 transgene expression 52 mRNA expression 52 Immunohistochemical staining 52 D. Feenan 52 CZERNO 52 K. Botsis 52 thymosin 52 K. Cuozzi 52 C. Blacklidg 52 HER2 expression 52 K. Finell 52 plasma leptin 52 -#.# ± [002] 52 K. Pulford 52 B. Moriarity 52 Randomized Phase 52 Rochon Salva 52 PETRO B. 52 monocyte chemotactic protein 52 Tor.Hunter 52 S.Drew 52 BLUE Sophia 52 HODGES K. 52 Vanchure 52 succinate dehydrogenase 52 Arnaud Tonus SUI 52 ^ sup #m 51 J.Nix 51 J.Drew 51 A.Casilla 51 FRIDEY M. 51 Fig. 2b 51 RODRIQUEZ C. 51 M.Tejada 51 S. Gilblair 51 CGuzman 51 WIMMER T. 51 Davide Guarneri ITA 51 Clement Desalle BEL Rockstar 51 colon carcinoma 51 PITTMAN Fran 51 NMIBC 51 Supplementary Fig 51 FRA Kawasaki 51 differentially regulated 51 gemcitabine cisplatin 51 J.Upton 51 DANIEL Kimi 51 BENNION D. 51 nmol l 51 B.Abreu 51 I.Suzuki 51 lysine residues 51 P. Siering 51 interleukin IL 51 C#BL 6 51 V.Martinez 51 #S #S [003] 51 J.Fox 51 Domecus S 51 spud #-#-# drlg [002] 51 N. Chucta 51 Simpson GBR KTM 51 EDSS score 51 M. Schepel 51 Kevin Strijbos BEL 51 M.Young 51 NEGRON K. 51 fig. S1 51 Fuster V 51 Am J Cardiol 51 C.Gonzalez 51 SCOGGINS B. 51 S. Evangelis 51 downregulated 51 2R 2RBI 51 ug kg 51 mg/m2/day 51 A.Hernandez 51 Mackenzie GBR Kawasaki 51 specific antigen PSA 51 Trigero 51 Tubulin 51 Jonathan Barragan ESP 51 DAVIS ATAGI 51 male Wistar rats 51 Recap NYY 51 D.Lee 51 Tanel Leok EST 51 Chad Gromek 51 #.#-#.# p = 51 Stoloski A. 51 RRM1 51 Y.Betancourt 51 VALIANTE K. 51 Jos.Reyes 51 RAUX 51 ATV RTV 51 cysteines 51 CK # plasma concentrations 51 MByrd 51 K. WHITTAKER 51 LAMPMAN E. 51 BoNT 51 Nature vol 51 MANUFACTURERS AND TRADERS 51 ertapenem 51 intratracheal 51 potently inhibited 51 K.Morales 51 baseman Ad.Gonzalez 51 BRUGMAN 51 E.Patterson 51 iNOS 51 J.Carroll 51 euthyroid 51 supernatants 51 NIX CLARK 51 C. VanKoever 51 W.Valdez 51 baseline FEV 51 W.Harris 51 GREENMAN 51 Reproduced Record RR 51 F.Gutierrez 51 L. Naig 51 hippocampal neurons 51 R. MAXON 51 Eddie Krawiec Harley Davidson 51 p td 51 normoxic 51 HT 1A 51 NAKAYAMA 51 tertile 51 microg 51 cells mcL 51 VIAFORA 51 ug dose 51 cytosolic 51 Gareth Swanepoel RSA 51 E.Johnson 51 K. Prunty 51 ITA Aprilia 51 SFinley 51 J.Lopez 51 Alb.Gonzalez 51 leukemia AML 51 creatine kinase MB 51 R.Sweeney 51 S. Slusher 51 hepatoma 51 SCHWARTZ R. 51 C.Jones 51 Y.Escobar 51 H.Kendrick 51 pmol L 50 J. Heidmann 50 J. Zembryski 50 J. VandenAkk 50 SUVmax 50 mcg albinterferon alfa 2b 50 ISuzuki 50 pg ml 50 M. Ercolano 50 Mueller Kri 50 Peginterferon Alfa 2a 50 deoxy 50 J.Wilson 50 I.Davis 50 Initiated Phase 50 M. Dodrill 50 SWOR S. 50 Delm.Young 50 Mi.Young 50 B. Libbe 50 B Gargon 50 C. Bodak 50 GPI anchored 50 serine threonine 50 KSP inhibitor 50 μmol 50 AEverett 50 median CD4 50 Tg mice 50 R.Paulino 50 Bolstad B. 50 A.Beltre 50 p = #.# [003] 50 K. Neurouter 50 CJones 50 Ha.Ramirez 50 K.Hill 50 % CI #.#-#.# [007] 50 bone marrow stromal cells 50 MEINHEIT J. 50 Clement Desalle BEL 50 μg liter 50 MUSSO 50 NO spud #-#-# 50 HENSLEY B. 50 A. Lasek 50 Bohannan Ri 50 MIC# [001] 50 Bumbry S 50 F.Sanchez 50 K. Gurzynski 50 underwent radical prostatectomy 50 J. Vriesman 50 Klaers A. 50 M.Ellis 50 autoreactive B 50 Toby Cheff Ronan 50 BClark 50 A.McCutchen 50 oocyst 50 mg/m2 dose 50 LINDLEY B. 50 Peginterferon 50 apolipoprotein B 50 F.Lopez 50 H.Ramirez 50 center fielder A.Jones 50 ShStewart 50 M.Young grounded 50 H.Matsui 50 E.Aybar 50 3ac 50 HALLOCK 50 J.Rivera 50 ROTOLA T. 50 A. Totaro 50 matrix metalloproteinases 50 dose dependently 50 SPENIA 50 W.Ramos 50 antibody titer 50 differentially expressed 50 P0 50 cynomolgus monkeys 50 Jim Thome dh 50 MADDEN K 50 E. faecalis 50 NTx 50 serum albumin 50 AGUIAR B. 50 Recap BAL 50 M.Ramirez 50 K. Maletsky 50 HGPIN 50 #b #b 50 Human Leukocyte Antigen 50 MYoung 50 R.Hernandez 50 Betaseron interferon beta 50 HELM B 50 BENBOW 50 nanomolar 50 colorectal adenoma 50 Jo.Lopez 50 K.Johnson 50 histological subtype 50 dosing cohort 50 Callison K. 50 HELLER A. 50 #.#/#.# mm Hg [003] 50 EYoung 50 GLEVENYAK 50 KALKA S. 50 serum IGF 50 immunoreactivity 50 HCV genotype 50 GRIJALVA A. 50 S.Rodriguez 50 phospho 50 K. Karp 50 #S #w 50 Ad.Gonzalez 50 mCi m 2 50 VanderAarde 50 E.Young 50 HEIDE J. 50 % Confidence Interval 50 GOODSON Just 50 RELF 50 Fraysher 50 intraperitoneally 50 syngeneic 50 overexpressing 50 dasatinib Sprycel ® 50 GIAMMARESI 50 JIMENEZ P. 50 ESQUER 50 MGiles 50 T. Tos 50 gag pol 50 B.Upton 50 HIV HCV coinfected 50 C.Santana 50 carlo.piovano @ thomson.com cp 50 BGiles 50 Jh.Peralta 50 BALF 50 AdGonzalez 50 LAZAR J. 50 Mariconda C 50 O'BRIEN Seth 50 #mg/m# [002] 50 A. Krushelny 50 selective phosphodiesterase 50 Dan.Murphy 49 KELLER P. 49 Adenoviral 49 Dan Bahorski 49 cellularity 49 SLAYTON J. 49 B.Francisco 49 LEARY J. 49 B.Phillips 49 D.Young 49 L. Politan 49 prospectively stratified 49 randomized #:# 49 Ron Krisher Cobalt 49 adriamycin 49 Ca.Lee 49 MACK Marcus 49 PURCELL FITU 49 5alpha reductase 49 highest tertile 49 Z. Roeder 49 Al.Ramirez 49 Evgeny Bobryshev RUS 49 J.Hamilton 49 PBMCs 49 LITZ 49 K.Matsui 49 RETURNING LETTERWINNERS Seniors 49 C.Patterson 49 3RBI 49 C.Pena 49 PHILLION 49 lipopolysaccharide LPS 49 M. Aggen 49 shortstop S.Castro 49 FOLDEN 49 non mutated KRAS 49 HR 2RBI 49 B.Roberts 49 mol L 49 caspofungin 49 PTACEK 49 EGFR HER2 49 GLI1 49 transgenic mice expressing 49 Stage IIIb 49 K. Beranek 49 2b 3b 49 Hvozdovic M 49 Brn 49 C.Jackson 49 prospectively randomized 49 daily subcutaneous injections 49 EATMON J. 49 A.Kennedy 49 § #E 49 doxorubicin cyclophosphamide 49 Ja.Wilson 49 VITEK 49 Wistar rats 49 PCA3 scores 49 A.Escobar 49 T. Jebb 49 Ar.Ramirez 49 R. Diemer 49 5-FU/LV 49 Deadlinepix 49 ERK signaling 49 min -1 49 BRoberts 49 Recap NYM 49 Cell Non Hodgkin 49 0 document.write sline 49 HCV genotypes 49 tumor xenograft models 49 M.Sweeney 49 irinotecan cisplatin 49 Wasiloski T 49 A.Jones 49 ara C 49 deacetylation 49 Me.Cabrera 49 Harri Kullas FIN 49 Neurol 49 Supplementary Table 49 serum concentrations 49 baseman Ad.LaRoche 49 FITU 49 M spud #-#-# 49 Polomcak S 49 mL/min/#.# m 2 49 intradermal injections 49 LENSKI 49 sarcomatoid 49 microdissected 49 0 document.write 49 B. Rickstad 49 P aeruginosa 49 Cancer Res 49 A.Soriano 49 drlg 49 Secretase 49 S.Castro 49 Fig. 1E 49 Jo.McDonald 49 ascending dose 49 GHRH 49 ASanchez 49 ligand receptor 49 BOLINGER 49 systolic dysfunction 49 multicenter randomized controlled 49 DAS# remission 49 M.Cameron 49 Dent Res 49 pegylated alpha interferon 49 MCKAIN S. 49 Fig. 3b 49 C.Davis 49 aminotransferase levels 49 Suppl. 49 Militz 49 N acetyl 49 typhi 49 Re.Johnson 49 STORRO 49 O.Hudson 49 CYP #D# 49 JKent 49 phosphorylated 49 Recap HOU 49 KLAFCZYNSKI 49 M. Tantum 49 TUNEL 49 HCV replicon 49 heme oxygenase 49 unfractionated heparin UFH 49 KMatsui 49 GUZZO 49 valine 49 M Yaworsky 49 antibody titers 49 orthotopic 49 0BB 49 histologic subtype 49 DNase 49 B.Molina 49 Zecchino M 49 FOLFIRI 49 prospectively defined 49 μg d 49 A.Rodriguez 49 J. Ferranti 49 mcg mL 49 μg doses 49 Greg Stanfield GXP 49 mRS 49 baseline A1C 49 DAS# scores 49 O.Cabrera 49 NANRY T. 49 REDS FIRST 49 N.Cruz 49 var = # [001] 49 D. Fodell 49 M.Saunders 49 BANTON J. 49 amplicons 49 Fig. 4B 49 A.Hill 49 benzothiazole 49 J.Buck 48 I.Rodriguez 48 Brockert E 48 Pelesz 48 precursor acute lymphoblastic 48 BREAM T. 48 ng dl 48 preoperative PSA 48 ciliated 48 shortstop Y.Escobar 48 E.Brown 48 Offensive Substitution 48 rf SAC RBI 48 multivariate Cox 48 cultured hippocampal neurons 48 genotyped 48 suppl. 48 C.Guzman 48 PD# [005] 48 1as 48 unpaired t 48 HIV RNA 48 1d 48 serum HBV DNA 48 linkage disequilibrium 48 HaRamirez 48 HOLLINGER E 48 Kruskal Wallis test 48 coding genes 48 RODEGHERO 48 iobenguane 48 nondiabetic patients 48 bile acid 48 PITTSBURGH PIRATES Placed 48 baseman B.Roberts 48 biopsy Gleason 48 Mar.Reynolds 48 Ad.LaRoche 48 plasma cortisol 48 M.Izturis 48 4RBI 48 χ 48 adiponectin concentrations 48 lf SF RBI 48 CLUFF 48 FAIMAN 48 TORGERSON 48 Docken J. 48 T.Hunter 48 LFord 48 5 Fluorouracil 48 Flu Cy 48 = sizeof 48 histologically 48 HAZELBAKER 48 BHall 48 REDAL C. 48 DRoberts 48 non CF bronchiectasis 48 An.LaRoche 48 CI #.#-#.# [001] 48 SCHAUS 48 DNA methyltransferases 48 L.Castillo 48 THEUNISSEN 48 APACHE II 48 NS5B 48 hypermethylated 48 Fig. 1A 48 A. Himmelfar 48 M Passante 48 #.# Kenyan Shilling 48 AJones 48 pan.pylas @ thomson.com pp 48 placebo controlled dose escalation 48 J. Bionde 48 mutated K ras 48 Kinesin 48 flavopiridol 48 baseman K.Johnson 48 cells uL 48 abacavir lamivudine 48 J'pot 48 fielder Nick Gorneault 48 leukocyte counts 48 BPhillips 48 left ventricular LV 48 Apolipoprotein 48 ,#,# [002] 48 log# copies mL 48 G.Anderson 48 ceftazidime 48 KGreene 48 hydrolase 48 fumagillin nanoparticles 48 A.Cabrera 48 dpa si 48 selectively binds 48 CAL POLY POMONA 48 POLLONI 48 dephosphorylation 48 CRoss 48 seropositivity 48 pleural fluid 48 transiently transfected 48 evaluable 48 glutamyl 48 JIMENEZ PJ 48 haematologic 48 semiquantitative 48 baseman C.Davis 48 fig. S2 48 metastatic malignant 48 antiretroviral naïve 48 J Hand Surg 48 potent inhibition 48 differential gene expression 48 microRNA molecule 48 #x# 3R 48 Javier Socor 48 Kaplan Meier estimates 48 Josh DeLara 48 HI titers 48 JUDD Latisha 48 HIF 1a 48 immunohistochemical analysis 48 polypoid 48 J.Molina 48 Gv 48 2r 48 Alberto Callaspo grounded 48 hemagglutination inhibition 48 Recap TEX 48 T#I [002] 48 ± SEM 48 pancreatic adenocarcinoma 48 Ad.Jones 48 elevated LDH 48 receptor inhibitor 48 allele frequencies 48 Insulin sensitivity 48 A.Dunn 48 pg mL 48 CK # administered 48 N. Gorneault 48 PAUL SAINTS Signed 48 R.Roberts 48 endonuclease 48 murine 48 A.Huff 48 coexpression 48 histopathologic examination 48 preintervention 48 Decitabine 48 bronchial responsiveness 48 baseman D.Lee 48 Interferon alfa 48 carboxyl terminal 48 BB HBP 48 matrix metalloprotease 48 FOLFIRI alone 48 pN 48 polyamine 48 SAMELA 48 multivariable adjusted 48 BCIRG 48 kappa B 48 DCruz 48 4E BP1 48 % CI #.#-#.# [001] 48 pairwise comparisons 48 chlorambucil 48 pT 48 Gardas K. 48 shortstop A.Cabrera 47 Rs.# w 47 Rab5 47 Miguel Tejada ss 47 lysate 47 E. Kloepping 47 dsRNA 47 agarose gel electrophoresis 47 Recap DET 47 +#:#.# [002] 47 mucinous 47 VEGFR1 47 lf SAC RBI 47 RECORD1 47 RPalmeiro 47 Camptosar ® 47 A.Gonzalez 47 cyclic AMP cAMP 47 antiretroviral naive 47 System IPSS 47 nmol liter 47 MCNAUGHTON 47 AKT inhibitor 47 interquartile range 47 MIVI TRUST 47 Yiznitsky 47 κ 47 STAT1 47 unfractionated 47 LS5 47 LuGonzalez 47 AST ALT 47 mouse mammary 47 JoLopez 47 Apolipoprotein B 47 thioredoxin 47 B.Giles 47 JEncarnacion 47 mU 47 acetylated 47 upregulated 47 SN #/#/# [003] 47 Recap TOR 47 p ≤ 47 mRCC 47 cDNA 47 troponin T 47 Schlosser CON 47 MESSERSCHMID 47 Recap LAA 47 lanthanum carbonate 47 DLTs 47 Kahalalide F 47 Pv 47 trimer 47 Fig. 1C 47 Avail 1Sept 47 Jeffrey Wu ENDITEM 47 CGuillen 47 serum urate levels 47 0K 47 K#R [002] 47 Figure 2C 47 Double Pinch Hitter 47 EEncarnacion 47 nanomolar range 47 SWITENKO 47 Recap WSH 47 BEL Kawasaki +#:#.# 47 transdermal estradiol 47 WASHINGTON NATIONALS Placed 47 lymphocyte proliferation 47 chi ^ sup 47 McNAUGHTON 47 underwent resection 47 D.Ortiz 47 1RBI 47 solithromycin 47 severe neutropenia 47 3b unassisted 47 PSA nadir 47 BENNETT B. 47 HOCH 47 Nancy Liu ENDITEM 47 purine 47 LAB GHRH 47 MiCabrera 47 viremic 47 Mileski B. 47 cTnI 47 2R 2ER 47 fig. S3 47 pCR 47 quantitative RT PCR